4.6 Medium
CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:L/AC:L/Au:N/C:P/I:P/A:P
8.8 High
CVSS3
Attack Vector
ADJACENT
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
7.3 High
AI Score
Confidence
Low
0.001 Low
EPSS
Percentile
38.8%
Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.
The following versions of Dana Diabecare Insulin Pumps and mobile applications are affected:
A hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.
CVE-2020-27256 has been assigned to this vulnerability. A CVSS v3 base score of 4.6 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N).
An information disclosure vulnerability in the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows unauthenticated attackers to extract the pump’s keypad lock PIN via Bluetooth Low Energy.
CVE-2020-27258 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).
The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy.
CVE-2020-27264 has been assigned to this vulnerability. A CVSS v3 base score of 7.6 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L).
A client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.
CVE-2020-27266 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).
A client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.
CVE-2020-27268 has been assigned to this vulnerability. A CVSS v3 base score of 6.5 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N).
The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.
CVE-2020-27269 has been assigned to this vulnerability. A CVSS v3 base score of 5.4 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:N/UI:R/S:U/C:L/I:H/A:N).
The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to protect encryption keys in transit, which allows unauthenticated, physically proximate attackers to sniff the keys via Bluetooth Low Energy.
CVE-2020-27270 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).
The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to authenticate the pump before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the keys and spoof the pump via Bluetooth Low Energy.
CVE-2020-27272 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).
The communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications does not use adequate measures to authenticate the communicating entities before exchanging keys, which allows unauthenticated, physically proximate attackers to eavesdrop the authentication sequence via Bluetooth Low Energy.
CVE-2020-27276 has been assigned to this vulnerability. A CVSS v3 base score of 5.7 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N).
Julian Suleder, Birk Kauer, Raphael Pavlidis, and Nils Emmerich of ERNW Research GmbH reported these vulnerabilities to the Federal Office for Information Security (BSI, Germany), in the context of the BSI project ManiMed – Manipulation of Medical Devices. BSI then provided this report to CISA.
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on us-cert.cisa.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
No known public exploits specifically target these vulnerabilities.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27256
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27258
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27264
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27266
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27268
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27269
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27270
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27272
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-27276
cwe.mitre.org/data/definitions/290.html
cwe.mitre.org/data/definitions/294.html
cwe.mitre.org/data/definitions/322.html
cwe.mitre.org/data/definitions/330.html
cwe.mitre.org/data/definitions/522.html
cwe.mitre.org/data/definitions/523.html
cwe.mitre.org/data/definitions/602.html
cwe.mitre.org/data/definitions/603.html
cwe.mitre.org/data/definitions/798.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=SOOIL%20Dana%20Diabecare%20RS%20Products+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01
us-cert.cisa.gov/ics
us-cert.cisa.gov/ics
us-cert.cisa.gov/ics/recommended-practices
us-cert.cisa.gov/ics/tips/ICS-TIP-12-146-01B
us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01&title=SOOIL%20Dana%20Diabecare%20RS%20Products
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:N/UI:R/S:U/C:L/I:H/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01
www.oig.dhs.gov/
www.surveymonkey.com/r/CISA-cyber-survey?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=SOOIL%20Dana%20Diabecare%20RS%20Products&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-21-012-01
4.6 Medium
CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:L/AC:L/Au:N/C:P/I:P/A:P
8.8 High
CVSS3
Attack Vector
ADJACENT
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
7.3 High
AI Score
Confidence
Low
0.001 Low
EPSS
Percentile
38.8%